Cetuximab as second-line therapy in patients with metastatic esophageal cancer: A phase II Southwest Oncology Group Study

Line Therapy ◽

Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181e77a92 ◽

2010 ◽

Vol 5 (9) ◽

pp. 1472-1476 ◽

Cited By ~ 36

Author(s):

Philip J. Gold ◽

Bryan Goldman ◽

Syma Iqbal ◽

Lawrence P. Leichman ◽

Wu Zhang ◽

...

Keyword(s):

Esophageal Adenocarcinoma ◽

Phase Ii ◽

Second Line ◽

Oncology Group ◽

Second Line Therapy ◽

Oncology Group Study ◽

Line Therapy ◽

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.07.024 ◽

2009 ◽

Vol 115 (2) ◽

pp. 285-289 ◽

Cited By ~ 20

Author(s):

James V. Fiorica ◽

John A. Blessing ◽

Louis V. Puneky ◽

Angeles Alvarez Secord ◽

James S. Hoffman ◽

...

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Single Agent ◽

Gynecologic Oncology Group ◽

Second Line ◽

Oncology Group ◽

Second Line Therapy ◽

Oncology Group Study ◽

Recurrent Carcinoma ◽

Line Therapy

Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study

Investigational New Drugs ◽

10.1007/bf00873146 ◽

1995 ◽

Vol 13 (4) ◽

pp. 363-365 ◽

Cited By ~ 2

Author(s):

Thomas R. Fleming ◽

Thomas D. Brown ◽

S. William Ross ◽

John S. Macdonald

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

Advanced Esophageal Cancer ◽

Oncology Group Study ◽

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study

Journal of Neuro-Oncology ◽

10.1007/bf01050266 ◽

1993 ◽

Vol 15 (1) ◽

pp. 75-77 ◽

Cited By ~ 116

Author(s):

J. Wendall Goodwin ◽

John Crowley ◽

Harmon J. Eyre ◽

Benjamin Stafford ◽

Kurt A. Jaeckle ◽

...

Keyword(s):

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19951201)76:11<2248::aid-cncr2820761111>3.0.co;2-y ◽

1995 ◽

Vol 76 (11) ◽

pp. 2248-2252 ◽

Cited By ~ 51

Author(s):

Stanley P. Balcerzak ◽

Jacqueline Benedetti ◽

Geoffrey R. Weiss ◽

Ronald B. Natale

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Trial ◽

Soft Tissue Sarcomas ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study

Investigational New Drugs ◽

10.1007/s10637-006-9244-8 ◽

2006 ◽

Vol 24 (6) ◽

pp. 537-542 ◽

Cited By ~ 7

Author(s):

James H. Doroshow ◽

Sheryl McCoy ◽

John S. Macdonald ◽

Brian F. Issell ◽

Taral Patel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Adenocarcinoma ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

American Journal of Hematology ◽

10.1002/ajh.20994 ◽

2007 ◽

Vol 82 (12) ◽

pp. 1056-1062 ◽

Cited By ~ 17

Author(s):

Stephen H. Petersdorf ◽

Cathryn Rankin ◽

David R. Head ◽

Howard R. Terebelo ◽

Cheryl L. Willman ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

High Dose ◽

Oncology Group ◽

Oncology Group Study ◽

High Dose Cytarabine ◽

Southwest Oncology Group Study ◽

Acute Myeloid

A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19910115)67:2<363::aid-cncr2820670208>3.0.co;2-h ◽

1991 ◽

Vol 67 (2) ◽

pp. 363-366 ◽

Cited By ~ 17

Author(s):

Louise M. Morrell ◽

Ardalan Bach ◽

Stephen P. Richman ◽

Phyllis Goodman ◽

Thomas R. Fleming ◽

...

Keyword(s):

Phase Ii ◽

Low Dose ◽

High Dose ◽

Oncology Group ◽

Short Term ◽

Oncology Group Study ◽

Southwest Oncology Group Study ◽

Adenocarcinoma Of The Pancreas

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

Investigational New Drugs ◽

10.1007/bf00216928 ◽

1990 ◽

Vol 8 (1) ◽

pp. 77-80 ◽

Cited By ~ 5

Author(s):

Sarah A. Taylor ◽

Thomas Fleming ◽

Daniel D. Von Hoff ◽

Joseph D. McCracken ◽

Ronald M. Bukowski ◽

...

Keyword(s):

Pancreatic Carcinoma ◽

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group Study ◽

Advanced Pancreatic Carcinoma

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdr021 ◽

2011 ◽

Vol 22 (12) ◽

pp. 2610-2615 ◽

Cited By ~ 91

Author(s):

S. Iqbal ◽

B. Goldman ◽

C.M. Fenoglio-Preiser ◽

H.J. Lenz ◽

W. Zhang ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Oncology Group ◽

First Line ◽

Oncology Group Study ◽

First Line Therapy ◽

Line Therapy ◽